The bald truth.
It may seem to pale in comparison to a lethal cancer diagnosis, but alopecia is reported by over half of women receiving chemotherapy for breast cancer as the most dreaded side effect. Roughly 9 of 10 women experience taxane-induced alopecia, and, while regrowth is expected to occur within 6 months, the majority of women suffer some degree of long term hair loss or thinning. Here is a descriptive look at 100 patients with chronic hair loss after chemo for breast cancer, revealing not only the clinical and histologic patterns but also the effective treatments virtually mirror that of androgenetic alopecia. In other words, this extremely common and deeply worrisome problem can be ameliorated with a healthy dose of Rogaine. | Bhoyrul, JAMA Dermatol 2021